Valery Grdzelishvili
Affiliations: | Biology (PhD) | University of North Carolina, Charlotte, Charlotte, NC, United States |
Area:
Virology Biology, Biochemistry, OncologyGoogle:
"Valery Grdzelishvili"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Andrea M. Murphy | grad student | 2012 | UNC Charlotte |
| Eric L. Hastie | grad student | 2014 | UNC Charlotte |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Goad DW, Nesmelova AY, Yohe LR, et al. (2023) Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells. Journal of Virology. 97: e0100523 |
| Goad DW, Bressy C, Holbrook MC, et al. (2021) Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Molecular Therapy Oncolytics. 24: 59-76 |
| Holbrook MC, Goad DW, Grdzelishvili VZ. (2021) Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions. Cancers. 13 |
| Seegers SL, Frasier C, Greene S, et al. (2019) Experimental evolution generates novel oncolytic vesicular stomatitis viruses with improved replication in virus-resistant pancreatic cancer cells. Journal of Virology |
| Bressy C, Droby GN, Maldonado BD, et al. (2018) Cell cycle arrest in G2/M phase enhances replication of interferon-sensitive cytoplasmic RNA viruses via inhibition of antiviral gene expression. Journal of Virology |
| Felt SA, Grdzelishvili VZ. (2017) Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update. The Journal of General Virology |
| Felt SA, Droby GN, Grdzelishvili VZ. (2017) Ruxolitinib and polycation combination treatment overcomes multiple mechanisms of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Journal of Virology |
| Bressy C, Hastie E, Grdzelishvili VZ. (2017) Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy. Molecular Therapy Oncolytics. 5: 20-40 |
| Hastie E, Cataldi M, Moerdyk-Schauwecker MJ, et al. (2016) Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Oncotarget |
| Cataldi M, Shah NR, Felt SA, et al. (2015) Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1. Virology. 485: 340-54 |